期刊： JOURNAL OF DRUG ASSESSMENT, 2023; 12 (1)
Background As the human immunodeficiency virus (HIV) treatment landscape continues to evolve, the prolonged life expectancy and long-term exposure to ......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Background Cardiogenic shock (CS) is an acute complex condition leading to morbidity and mortality. Vasoactive medications, such as vasopressors and i......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Purpose: To report the clinical course of a woman treated with intravitreal bevacizumab during pregnancy. Case report: A 27-year-old female with poorl......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Background: There have been significant advances in Cystic Fibrosis (CF) treatment, with the introduction of Cystic Fibrosis Transmembrane Conductance......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Acute repetitive seizures, also called seizure clusters, are common phenomena in patients with epilepsy. They are a burden on patients and their careg......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Objective: This study aimed to compare the therapeutic efficacy and safety of dorzolamide/timolol fixed-combination(Cosopt) in newly diagnosed primary......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Background: H. pylori infection is associated with both benign and malignant gastrointestinal diseases. However, no studies have been conducted locall......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Background: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in humans and the mainstay of treatment is anticoagulation unless contrain......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Objective To explore treatment preferences of patients with Hereditary Angioedema (HAE), a debilitating disorder characterized by potentially life-thr......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Aims: The ability of a patient to receive anti-cancer treatment depends on a variety of factors, including performance status (PS), which is typically......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Objective The purpose of this study is to review CDK 4/6 inhibitors used to treat metastatic breast cancer for patient safety, cost and utilization. B......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Objective: Hyperhidrosis (excessive sweating) is associated with significant quality-of-life burden yet is often undertreated. With limited FDA-approv......
期刊： JOURNAL OF DRUG ASSESSMENT, 2021; 10 (1)
Purpose: Cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) is a treatment for post-transplant lymphoproliferative disease (PTLD) following......
期刊： JOURNAL OF DRUG ASSESSMENT, 2020; 9 (1)
Objectives: Fear of opioid withdrawal syndrome (OWS) often dissuades opioid discontinuation. Lofexidine is an FDA-approved, alpha(2)-adrenergic recept......
期刊： JOURNAL OF DRUG ASSESSMENT, 2020; 9 (1)
Objectives: To compare the risks of 1-month all-cause, major bleeding (MB)-related and stroke-related readmissions and the associated hospital resourc......
